ÂÜÀòÂÒÂ×

Jeremy O'Hanlon is an experienced professional in global business development and corporate strategy, currently serving as Executive Director at Daiichi Sankyo, Inc. Previously, Jeremy held the position of VP, Head of Business/Corporate Development at Stealth Biotech Co, and served as Director of Corporate Development at Gilead Sciences. Jeremy's background also includes roles in business development with AstraZeneca, focusing on scientific partnering and alliances, as well as experience as a corporate attorney at Fenwick & West. Jeremy O'Hanlon holds a Master of Laws (LLM) from the University of California, Berkeley - School of Law, and a Master of Philosophy (MPhil) in Chemical Engineering and Biotechnology from the University of Cambridge.